Literature DB >> 27278048

A case of significantly increased mitral regurgitation early after atrial septal defect closure.

Masataka Nishiga1, Chisato Izumi2, Hayato Matsutani3, Sumiyo Hashiwada3, Shuichi Takahashi3, Yukiko Hayama2, Seiko Nakajima2, Jiro Sakamoto2, Koji Hanazawa2, Makoto Miyake2, Toshihiro Tamura2, Hirokazu Kondo2, Makoto Motooka2, Kazuaki Kaitani2, Yoshihisa Nakagawa2.   

Abstract

We report a rare case in which mitral regurgitation (MR) was exacerbated to a severe level early after atrial septal defect (ASD) closure, even though the female patient had preoperatively mild MR and mild changes in mitral valve (MV) and sinus rhythm. The mechanism of increased MR was considered as poor coaptation and tethering of the MV due to the restricted motion of the posterior leaflet in addition to geometric changes of the left ventricle (LV) after ASD closure.

Entities:  

Keywords:  ASD plaque; Atrial septal defect; Echocardiography; Geometric change; Mitral regurgitation; Tethering

Year:  2012        PMID: 27278048     DOI: 10.1007/s12574-012-0123-3

Source DB:  PubMed          Journal:  J Echocardiogr        ISSN: 1349-0222


  3 in total

1.  Deterioration of mitral valve competence after the repair of atrial septal defect in adults.

Authors:  Jeong-Jun Park; Seung Chul Lee; Joon Bum Kim; Deok-Jin Seo; Jong-Min Song; Sung-Cheol Yun; Tae-Jin Yun
Journal:  Ann Thorac Surg       Date:  2011-09-21       Impact factor: 4.330

2.  Mitral valve lesion associated with secundum atrial septal defect. Analysis by real time two dimensional echocardiography.

Authors:  S Nagata; Y Nimura; H Sakakibara; S Beppu; Y D Park; K Kawazoe; T Fujita
Journal:  Br Heart J       Date:  1983-01

3.  Preoperative and postoperative mitral valve prolapse and regurgitation in adult patients with secundum atrial septal defects.

Authors:  Manatomo Toyono; Gosta B Pettersson; Yoshiki Matsumura; Nozomi Wada; Shota Fukuda; Tetsuhiro Yamano; Kunitsugu Takasaki; Takahiro Shiota
Journal:  Echocardiography       Date:  2008-09-02       Impact factor: 1.724

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.